Lux Capital > Research > The Nanotech Report 2003 > Dealbook


 

THE NANOTECH REPORT 2003 (Newly Released: July 2003)

Package includes what publicly traded companies are doing in nanotechnology, how they're staying competitve, and which private companies are best positioned for IPOs:

Free Download of 38-page introduction and table of contents
+ +
The Nanotech Report 2003
500+ page market research and investment
overview for nanotechnology
  Forbes/Wolfe Nanotech Report
1-year subscription to nanotech's leading monthly investment report

learn more...
(model stock portfolio up 90% since March 2002)
  The NanoBusiness Alliance Industry Directory
Listing of over 700 companies involved in nanotechnology

INSIDE THE NANOTECH REPORT 2003

  • Interviews and expert weigh-in from the world's leading researchers and Nobel Laureates in materials science, chemistry, physics, biology, and engineering.
  • Ranking of the 25 Most Influential People in Nanotechnology
  • Trends in US and International Academic Institutions
  • Venture Capital Activity & Deals in Nanotechnology
  • Thematic Framework for Private Equity Investing
  • Over 500 Charts, Tables, Graphs, & Illustrations
  • Over 700 Public and Private Companies Listed
  • Over 20 Academia Initiatives & IP Licensing
  • Trends in US and International Governments
  • Nanobiotech: Major R&D Initiatives at Biotechnology Firms
  • Strategies for Public Market Investing
  • In-depth Patent Trends and Analysis
  • Scientific & Technical Explanations
  • Full Glossary

The original ideas, projections and strategies in Lux Capital's 2001 "The Nanotech Report" introduced institutional investors to nanotechnology on a worldwide basis, first with Merrill Lynch and most recently through Credit Suisse First Boston. The Nanotech Report was the first to recommend following government funding as a driver to invest in nanotech tool providers. Many of the other trends we identified in The Nanotech Report have become the basis for corporate and investment strategies.

The Nanotech Report 2003 reveals new public market and private equity investment themes, profiles more than 700 public and private companies, and analyzes the intellectual property positions of major corporations and startups to help identify potential winners and losers. The Nanotech Report 2003 uncovers leading government laboratories and academic researchers at the forefront of nanotechnology, ranks the most influential people in the field and highlights venture capital and worldwide government funding trends.

Nanotechnology, the manipulation and control of matter at the molecular level, has widely been recognized as critical for the future of economic and regional competitiveness, job creation, and technological superiority. In The Nanotech Report 2003, we demonstrate how nanotechnology affects every existing industry, from Chemicals, Textiles/Apparel, Computing and Storage, to Transportation, Energy, Power, Healthcare and Homeland Security.

In 2003, there will be more than $3 billion of government funding worldwide going towards centers of nanoscale research. Nanotechnology is the Bush Administration's highest science and technology priority in the 2004 fiscal year. On May 7, 2003 the U.S. House of Representatives approved a $2.4 billion bill to continue the United States' National Nanotechnology Initiative over the next three years. Nanotechnology will be the largest government-funded science program since the Space Race, exceeding even the Human Genome Project.

This report provides a roadmap for the nanotechnology industry and illustrates how senior executives and investors can exploit the prevailing trends to maintain a competitive advantage.

If you are interested in purchasing this report, please contact us at orders@luxcapital.com


SAMPLE PAGES



 



Research and development and expert commentary on leading Public and Private Companies such as (partial listings):

Chemicals/Specialty Chemicals Companies

BASF [BF], Dow [DOW], DuPont [DD], Symyx
[SMMX], Carbon Nanotechnologies Inc., Nano-Tex

Biotechnology & Pharmaceuticals
Flamel Technologies [FLML], SkyePharma [SKYE], Merck [MRK], Surface Logix, Pharmacopeia [PCOP], IMedd Technologies, Genicon Sciences, C-Sixty

Energy & Power
Exxon Mobil [XOM], Fuel Cell Energy [FCEL], Chevron Texaco [CVX]

Semiconductor Capital Equipment
Veeco [VECO], FEI Company [FEIC]
, JPK Instruments, Molecular Imprints

Computing & Storage
IBM [IBM], Hewlett-Packard [HPQ], NEC [NIPNY], Motorola [MOT]
, Nanosys


"Corporate executives should leverage The Nanotech Report as a guidebook to understand and take advantage of this vast technological change."
-- George Elling, Managing Director, Deutsche Bank Technology Group


"A superb industry and technology primer, The Nanotech Report shows investors a rare insider's view into the leading nanotechnology research labs. This report gives a clear and sober perspective of the nanotechnology revolution that will provide investors and scientists the edge they need to compete in this field." -- Charles Musgrave, Ph.D., Stanford University (First Feynman Prize in Nanotechnology, 1993)


"This is a marvelous piece of work. In terms of significance and potential impact, The Nanotech Report reminds me of Morgan Stanley's The Internet Report when I was co-writing it. This is the definitive study and investor road map for the nanotechnology industry. Whether you're a scientist, investor, or technology entrepreneur, it's clear---these guys get it."
-- Chris DePuy, General Partner, Bowman Capita
l